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Acute inflammation increases pro-inflammatory cytokine production and reduces nitric oxide 
bioavailability, resulting in impaired vascular function. Estrogen has both anti-inflammatory and pro-
vasodilatory properties. During the high estrogen, mid-luteal phase of the menstrual cycle, sex 
differences in vascular function and inflammatory responses to induced inflammation have been 
observed in premenopausal women as compared with age-matched men. PURPOSE: To evaluate sex 
differences in vascular responses to induced inflammation- with a reduced influence of estrogen 
concentration. METHODS: In a double-blind crossover sham-controlled study of 15 women (21±3y) 
and 15 men (21±2y), we assessed pro-inflammatory interleukin-6 concentration ([IL-6]) and vascular 
function via brachial artery flow mediated dilation (FMD) at baseline (BL), 24 hours (24H), and 48 
hours (48H) after influenza vaccine administration. Women were studied when circulating estrogen 
levels are typically low (early follicular phase or placebo pill phase of oral contraceptive pills) and 
similar between sexes. RESULTS: Following induced inflammation, both sexes exhibited an increase 
in [IL-6] at 24H (BL v 24H: women p=0.0024; men p=0.0029) that returned to near baseline levels by 
48H (BL v 48H: women p=0.64; men p=0.30; [IL-6] (pg/mL): women BL: 0.54 ± 0.5, 24H: 1.12 ± 0.6, 
48H: 0.57 ± 0.3; men BL: 0.39 ± 0.2, 24H: 1.07 ± 0.7, 48H: 0.58 ± 0.2). There were no sex differences 
in FMD or [IL-6] at any time point (FMD: sex p=0.062, time p=0.30, interaction p=0.25; FMD (%): 
women BL: 8.33 ± 4.8, 24H: 6.40 ± 4.4, 48H: 9.05 ± 5.5; men: BL: 5.25 ± 2.9, 24H: 6.14 ± 2.1, 48H: 
6.71 ± 1.1; [IL-6]: BL: p=0.74, 24H: p=0.57, 48H: p=0.66). Though, women exhibited significantly 
lower resting brachial artery diameter (BL D; p<0.0001 all time points) than men (BL D (mm): women 
BL: 3.22 ± 0.4, 24H: 3.18 ± 0.4, 48H: 3.19 ± 0.4; men BL: 4.07 ± 0.6, 24H: 4.24 ± 0.4, 48H, 4.22 ± 
0.4). However, there were no sex differences in allometrically scaled FMD (sex p=0.11, time p=0.20, 
interaction p= 0.072; Scaled FMD (%): women BL: 6.39 ± 3.7, 24H: 4.32 ± 3.8, 48H: 6.92 ± 3.7; men 
BL: 7.03 ± 3.9, 24H: 8.71 ± 4.2, 48H: 8.69 ± 4.3). CONCLUSION: When estrogen concentrations are 
low, women show similar inflammatory responses and vascular function as compared with age-
matched men.   
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